Search clinical trials for: 0.01% CT327 (or placebo)
Total 1192 results
-
Vasomune Therapeutics, Inc.CompletedCovid19 | ARDS | Covid19-associated ARDSUnited States
-
Balance TherapeuticsCompletedIdiopathic Hypersomnia | Narcolepsy Without CataplexyUnited States
-
Xenon Pharmaceuticals Inc.CompletedDental PainUnited States
-
AbbottCompletedExocrine Pancreatic Insufficiency, Chronic PancreatitisJapan
-
Swedish Orphan BiovitrumCompleted
-
Daewoong Bio Inc.CompletedDry Eye SyndromesKorea, Republic of
-
Duramed ResearchCompletedDysmenorrheaUnited States
-
SIFI SpACompletedAcanthamoeba KeratitisItaly, United Kingdom, Poland
-
Jiangsu HengRui Medicine Co., Ltd.China-Japan Friendship HospitalCompletedType 2 DiabetesChina
-
Latigo BiotherapeuticsRecruiting
-
MedRegen LLCJohns Hopkins University; ICON plcRecruitingCOVID-19 | ARDS, Human | Regeneration | Stem CellsUnited States
-
Nacuity Pharmaceuticals, Inc.Foundation Fighting BlindnessActive, not recruitingUsher SyndromesAustralia
-
Alumis IncCompletedPlaque PsoriasisUnited States, Canada, Czechia
-
Anebulo PharmaceuticalsCompletedAcute Cannabinoid IntoxicationNetherlands
-
Bloom ScienceCompleted
-
Ixaka LtdAndalusian Network for Design and Translation of Advanced TherapiesTerminatedCardiovascular Disease | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Critical Limb Ischemia (CLI) | Peripheral Arterial Disease (PAD) | Diabetes Mellitus (DM)Spain, Netherlands, United Kingdom, Czechia, Portugal, Hungary
-
PfizerCompletedScar PreventionUnited States
-
Novo Nordisk A/SCompleted
-
Ixaka LtdAndalusian Network for Design and Translation of Advanced TherapiesTerminatedCardiovascular Disease | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Critical Limb Ischemia (CLI) | Peripheral Arterial Disease (PAD) | Diabetes Mellitus (DM)Spain, Czechia, Portugal, Hungary, Germany, Poland
-
Xenon Pharmaceuticals Inc.CompletedInherited Erythromelalgia | Primary ErythromelalgiaNetherlands
-
Hoffmann-La RocheCompletedChronic Hepatitis CUnited States, Puerto Rico
-
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.Not yet recruiting
-
Qlaris Bio, Inc.Not yet recruitingGlaucoma | Normal Tension Glaucoma (NTG) | Low-Tension Glaucoma, Bilateral | Low-Tension Glaucoma, Unspecified EyeKorea, Republic of, Philippines
-
PharmacobioRecruitingAlzheimer DiseaseKorea, Republic of
-
Xiaolin Chen, MDRecruitingSubarachnoid Hemorrhage, AneurysmalChina
-
Xentria, Inc.RecruitingPulmonary SarcoidosisUnited States, United Kingdom
-
Suzhou Kintor Pharmaceutical Inc,Terminated
-
Autophagy Sciences, Inc.Completed
-
Acceleron Pharma Inc. (a wholly owned subsidiary...Completed
-
PfizerCompletedDiabetes Mellitus, Type 2United States
-
Akros Pharma Inc.CompletedDiabetes MellitusUnited States
-
Dr. Reddy's Laboratories LimitedPharmaNetCompletedType II HyperlipidemiaUkraine, Poland, Italy
-
Ritter Pharmaceuticals, Inc.CompletedLactose IntoleranceUnited States
-
Akros Pharma Inc.Completed
-
BenevolentAI BioCompletedAtopic DermatitisUnited Kingdom
-
Formosa Pharmaceuticals, Inc.CompletedOcular Inflammation and Pain After Cataract SurgeryUnited States
-
Formosa Pharmaceuticals, Inc.CompletedOcular Inflammation and PainUnited States, Puerto Rico
-
University of PennsylvaniaNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Failure With Preserved Ejection Fraction | Low Triiodothyronine SyndromeUnited States
-
PfizerCompleted
-
AnaMar ABCovanceCompletedAtopic DermatitisUnited Kingdom
-
AmgenTerminated
-
AmgenCompletedPsoriasisNew Zealand, Australia
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedBiomarkerUnited Kingdom
-
PfizerCompleted
-
PfizerTerminated
-
PfizerCompleted
-
Auris Medical, Inc.CompletedTinnitusUnited States, Germany, Belgium, Poland
-
BiotestCompletedPsoriasis VulgarisCzech Republic, Hungary